These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 31899982)
1. Current and emerging therapeutic options for the management of functional dyspepsia. Vandenberghe A; Schol J; Van den Houte K; Masuy I; Carbone F; Tack J Expert Opin Pharmacother; 2020 Feb; 21(3):365-376. PubMed ID: 31899982 [No Abstract] [Full Text] [Related]
2. Drugs under development for the treatment of functional dyspepsia and related disorders. Tack J; Masuy I; Van Den Houte K; Wauters L; Schol J; Vanuytsel T; Vandenberghe A; Carbone F Expert Opin Investig Drugs; 2019 Oct; 28(10):871-889. PubMed ID: 31566013 [No Abstract] [Full Text] [Related]
7. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria. Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284 [TBL] [Abstract][Full Text] [Related]
8. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia. Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S Digestion; 2017; 96(1):5-12. PubMed ID: 28605740 [TBL] [Abstract][Full Text] [Related]
9. Real-World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Treatment of Functional Dyspepsia. Porika SK; Veligandla KC; Muni SK; Acharya S; Mehta SC; Sharma AD Adv Ther; 2018 Nov; 35(11):1884-1893. PubMed ID: 30350248 [TBL] [Abstract][Full Text] [Related]
11. The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia. Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kawarai Lefor A; Yamamoto H J Med Invest; 2016; 63(3-4):230-5. PubMed ID: 27644564 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of acotiamide for the treatment of functional dyspepsia. Sun Y; Song G; McCallum RW Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1161-8. PubMed ID: 24881488 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Postprandial Symptom Patterns in Subgroups of Patients With Rome III or Rome IV Functional Dyspepsia. Carbone F; Vanuytsel T; Tack J Clin Gastroenterol Hepatol; 2020 Apr; 18(4):838-846.e3. PubMed ID: 31394286 [TBL] [Abstract][Full Text] [Related]
14. Effects of Rome IV Definitions of Functional Dyspepsia Subgroups in Secondary Care. Van den Houte K; Carbone F; Goelen N; Schol J; Masuy I; Arts J; Caenepeel P; Staessen D; Vergauwe P; Van Roey G; Latour P; Piessevaux H; Maldague P; Gerkens A; Wuestenberghs F; Vandenberghe A; Tack J Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1620-1626. PubMed ID: 32645450 [TBL] [Abstract][Full Text] [Related]
15. The Role of Duodenal Inflammation in Functional Dyspepsia. Walker MM; Talley NJ J Clin Gastroenterol; 2017 Jan; 51(1):12-18. PubMed ID: 27811629 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy. Mayanagi S; Kishino M; Kitagawa Y; Sunamura M Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232 [TBL] [Abstract][Full Text] [Related]